Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder.
Bechdolf A, Ratheesh A, Wood SJ, Tecic T, Conus P, Nelson B, Cotton SM, Chanen AM, Amminger GP, Ruhrmann S, Schultze-Lutter F, Klosterkötter J, Fusar Poli P, Yung AR, Berk M, McGorry PD.
Bechdolf A, et al. Among authors: ratheesh a.
Curr Pharm Des. 2012;18(4):358-75. doi: 10.2174/138161212799316226.
Curr Pharm Des. 2012.
PMID: 22239567
Review.